Journal of Cardiovascular Pharmacology and Therapeutics: 2022, vol: 27, issue:
- 1)- María González Valdivieso, Domingo Orozco-Beltrán, Adriana López-Pineda, Vicente Francisco Gil-Guillén, José A Quesada, Concepción Carratalá-Munuera, Rauf Nouni-García. Early Detection of Atrial Fibrillation in Community Pharmacies-CRIFAFARMA Study. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221078973
Cited : 3Read More - 2)- Robert W Ariss, Rajesh Gupta. Estimated Aggregate Treatment Benefit With Addition of Multiple Novel Medications for Secondary Prevention of Atherosclerotic Cardiovascular Disease. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221084772Cited : 1Read More
- 3)- Wayne Kaesemeyer, Tatsiana Suvorava. Nitric Oxide Is the Cause of Nitroglycerin Tolerance: Providing an Old Dog New Tricks for Acute Heart Failure. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221086091Cited : 1Read More
- 4)- Melanie Gartz, Margaret Haberman, Mariah J Prom, Margaret J Beatka, Jennifer L Strande, Michael W Lawlor. A Long-Term Study Evaluating the Effects of Nicorandil Treatment on Duchenne Muscular Dystrophy-Associated Cardiomyopathy in Mice. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221088655Cited : 1Read More
- 5)- Nicole K Early, Kelsey Buckley, Nana Entsuah, Kathleen A Fairman. Association of Cardiovascular Disease and Military Veteran Status With Impairments in Physical and Psychological Functioning: Retrospective Cross-Sectional Analysis of US National Survey Data. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221091015Cited : 1Read More
- 6)- . Corrigendum to "Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombus: A Retrospective, Multicenter Study and Meta-Analysis of Existing Data". Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221091047Cited : 0Read More
- 7)- Patricia P Wadowski, Joseph Pultar, Constantin Weikert, Beate Eichelberger, Maximilian Tscharre, Renate Koppensteiner, Simon Panzer, Thomas Gremmel. Platelet-to-Lymphocyte Ratio as Marker of Platelet Activation in Patients on Potent P2Y Inhibitors. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221096524Cited : 2Read More
- 8)- Helmut Raphael Lieder, Pia Tüller, Felix Braczko, Afsaneh Zandi, Markus Kamler, Matthias Thielmann, Gerd Heusch, Petra Kleinbongard. Bioassays of Humoral Cardioprotective Factors Released by Remote Ischemic Conditioning in Patients Undergoing Coronary Artery Bypass Surgery. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221097273Cited : 7Read More
- 9)- Caroline Coppinger, Mohammad Reza Movahed, Veronica Azemawah, Lee Peyton, James Gregory, Mehrnoosh Hashemzadeh. A Comprehensive Review of PCSK9 Inhibitors. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221100107Cited : 43Read More
- 10)- Christian A Bernhardi, Stephen Fendt, Brent N Reed, Gautam Ramani, Stormi E Gale. Continuation Versus Interruption of Renin-Angiotensin System Inhibitors in Acute Decompensated Heart Failure: A Brief Report. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221100127Cited : 0Read More
- 11)- Paolo Cimaglia, Davide Bernucci, Laura Sofia Cardelli, Anna Carone, Giuseppe Scavone, Marco Manfrini, Stefano Censi, Simone Calvi, Roberto Ferrari, Gianluca Campo, Luca Dalla Paola. Renin-Angiotensin-Aldosterone System Inhibitors, Statins, and Beta-Blockers in Diabetic Patients With Critical Limb Ischemia and Foot Lesions. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221101980Cited : 2Read More
- 12)- Ariel Roguin, Ofer Kobo, Simcha Ron Meisel, Emad Maraga, Aaron Frimerman, Naama Amsalem, Rinat Malka, Yaniv Levi, Rami Abu Fanne. Morphine Use in ST-Elevation Myocardial Infarction With Downstream PY Receptor Blockers-Insight From Observational Study. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221107793Cited : 1Read More
- 13)- Po-Lin Lin, Ying-Hsiang Lee, Lawrence Yu-Min Liu, Cheng-Ting Tsai, Ten-Fang Yang, Wei-Ru Chiou, Mu-Yang Hsieh, Hung-Yu Chang, Chun-Che Huang. Duration of Heart Failure With Reduced Ejection Fraction Associated With Electrocardiographic Outcomes Before and After Sacubitril/Valsartan. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221107799Cited : 2Read More
- 14)- Estefanny Villar-Matamoros, Lauren Stokes, Alyssa Lloret, Meagan Todd, Bryan W Tillman, Saami K Yazdani. Understanding the Mechanism of Drug Transfer and Retention of Drug-Coated Balloons. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221119559Cited : 5Read More
- 15)- C Michael Gibson, Syed Hassan A Kazmi, Serge Korjian, Gerald Chi, Adam T Phillips, Sahar Memar Montazerin, Danielle Duffy, Bo Zheng, Mark Heise, Charles Liss, Lawrence I Deckelbaum, Samuel D Wright, Andreas Gille. CSL112 (Apolipoprotein A-I [Human]) Strongly Enhances Plasma Apoa-I and Cholesterol Efflux Capacity in Post-Acute Myocardial Infarction Patients: A PK/PD Substudy of the AEGIS-I Trial. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221121507Cited : 12Read More
- 16)- Dannick Brochu, Amélie St-Arnaud, Louis-Étienne Marchand, Pierre Voisine, Julie Méthot. Impact of COVID-19 on the Prescribing Pattern of Oral Anticoagulants for Atrial Fibrillation After Cardiac Surgery. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221128124Cited : 2Read More
- 17)- Eman El-Khateeb, Sahar Mohamed El-Haggar, Osama El-Razaky, Mohamed Ramadan El-Shanshory, Tarek Mohamed Mostafa. Randomized Clinical and Biochemical Study Comparing the Effect of L-arginine and Sildenafil in Beta Thalassemia Major Children With High Tricuspid Regurgitant Jet Velocity. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221132671Cited : 0Read More
- 18)- Selçuk Şen, Denizhan Demirkol, Mert Kaşkal, Murat Gezer, Ayşenur Yaman Bucak, Nermin Gürel, Yasemin Selalmaz, Çiğdem Erol, Ali Yağız Üresin. Evaluation of Risk Factors Associated With Antihypertensive Treatment Success Employing Data Mining Techniques. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221136758Cited : 0Read More
- 19)- Nenad Ilijevski, Igor Atanasijević, Branko Lozuk, Predrag Gajin, Predrag Matić, Srđan Babić, Dragan Sagić, Dragana Unić-Stojanović, Slobodan Tanasković. Direct Ischemic Postconditioning After Carotid Endarterectomy in the Prevention of Postoperative Cerebral Ischemic Complications-Observational Case-Control Study. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221137489Cited : 2Read More
- 20)- Alberico L Catapano, Michal Vrablik, Yuri Karpov, Baptiste Berthou, Megan Loy, Marie Baccara-Dinet. A Phase 3 Randomized Controlled Trial to Evaluate Efficacy and Safety of New-Formulation Zenon (Rosuvastatin/Ezetimibe Fixed-Dose Combination) in Primary Hypercholesterolemia Inadequately Controlled by Statins. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221138284Cited : 2Read More
- 21)- Joseph D English, Shuo Tian, Zhong Wang, Jasmine A Luzum. Association of Valproic Acid Use With Post-Myocardial Infarction Heart Failure Development: A Meta-Analysis of Two Retrospective Case-Control Studies. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221140303Cited : 2Read More
- 22)- Jorge L Reyes, Charles A Herzog, Heng Yan, Nicholas S Roetker, James B Wetmore. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221142220Cited : 6Read More
- 23)- James C Coons, James M Stevenson, Ami Patel, A J Conrad Smith, Linda Prebehalla, Philip E Empey. Antiplatelet Therapy and Bleeding Outcomes With CYP2C19 Genotyping. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221143246Cited : 1Read More
- 24)- Emir M Muzurović, Špela Volčanšek, Karin Zibar Tomšić, Andrej Janež, Dimitri P Mikhailidis, Manfredi Rizzo, Christos S Mantzoros. Glucagon-Like Peptide-1 Receptor Agonists and Dual Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in the Treatment of Obesity/Metabolic Syndrome, Prediabetes/Diabetes and Non-Alcoholic Fatty Liver Disease-Current Evidence. Journal of cardiovascular pharmacology and therapeutics. 2022, 27: 10742484221146371Cited : 30Read More
